Remove Genetic Engineering Remove Genetics Remove Scientist
article thumbnail

Sloan Kettering Institute Scientists retool CAR T cells to serve as ‘micropharmacies’ for cancer drugs

Scienmag

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. Now, scientists at Memorial Sloan Kettering Cancer Center’s Sloan Kettering Institute (SKI) have developed new CAR T cells that can do something their […].

article thumbnail

New ‘split-drive’ system puts scientists in the (gene) driver seat

Scienmag

Researchers develop tunable system that harnesses the spread of cargo carried by gene drives Credit: Gerard Terradas, UC San Diego Powerful new genetic engineering methods have given scientists the potential to revolutionize several sectors of global urgency.

Gene 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Flipping light on-off turns bacteria into chemical factories

Scienmag

Credit: Avalos Lab/Princeton University Researchers at Princeton University have created a new and improved way to more precisely control genetically engineered bacteria: by simply switching the lights on and off. Working in E.

article thumbnail

Cataloging nature’s hidden arsenal: Viruses that infect bacteria

Scienmag

A new genetic approach can accelerate the study of phage-microbe interactions with implications for health, agriculture, and climate Credit: Wikimedia Commons Scientists are continually searching for new and improved ways to deal with bacteria, be it to eliminate disease-causing strains or to modify potentially beneficial strains.

article thumbnail

Synergy between biotech and classical control tactics rid US of invasive pest

Scienmag

Credit: Agricultural Research Service-USDA.

article thumbnail

First launch for Daiichi Sankyo’s oncolytic virus Delytact in Japan

pharmaphorum

Delytact (teserpaturev) is a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1) that was approved for marketing in Japan earlier this year, and received pricing approval in August at 1.43 It was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo.

article thumbnail

AI-designed serotonin tracker could help develop neurology drugs

pharmaphorum

A serotonin sensor designed using Artificial Intelligence (AI) could help scientists study sleep and mental health and potentially find new neurology drugs. After three rounds of testing, the scientists settled on one. The researchers used machine learning algorithms to help a computer ‘think up’ 250,000 new designs.